Celiac disease patients presenting with anemia have more severe disease than those presenting with diarrhea

Hussein Abu Daya1, Benjamin Lebwohl, Suzanne K Lewis

  • 1Celiac Disease Center, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York.

Insights

Patients with celiac disease presenting with anemia, a silent symptom, have more severe disease than those with diarrhea. Anemia in celiac disease is linked to worse outcomes and requires further investigation.

Area of Science:

  • Gastroenterology
  • Internal Medicine
  • Hematology

Background:

  • Celiac disease (CD) is an autoimmune disorder.
  • CD classically presents with diarrhea, but anemia is a recognized atypical presentation.
  • Disease severity comparison between these presentations is not well-established.

Purpose of the Study:

  • To compare the severity of celiac disease in patients presenting with anemia versus those presenting with diarrhea.
  • To identify clinical, serologic, and bone density differences between these groups.

Main Methods:

  • Retrospective analysis of 727 celiac disease patients diagnosed between 1990-2011.
  • Severity assessed by villous atrophy, clinical, and serologic markers.
  • Multivariable regression adjusted for age and sex.

Main Results:

  • 23% of patients presented with anemia (92% iron deficient) vs 77% with diarrhea.
  • Anemia presentation associated with lower cholesterol, higher ESR, and higher anti-tissue transglutaminase.
  • Anemic patients had higher likelihood of severe villous atrophy and low bone density.

Conclusions:

  • Anemia presentation indicates more severe celiac disease compared to diarrhea presentation.
  • Sex-specific differences observed in the association between anemia and CD features.
  • Anemia as a presentation of celiac disease warrants thorough evaluation for disease severity.
Abstract

Related Concept Videos

Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

Factors Influencing Drug Absorption: Disease States and Pharmacology

Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...